Skip to main content
HR 2194 112th Congress House Health Advisory bodies Digestive and metabolic diseases Health information and medical records Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Sex and reproductive health Women's health

GEDI Act

Introduced: July 10, 2012 See on congress.gov
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 22, 2011
Referred to the Subcommittee on Health.
Jun 15, 2011
Referred to the House Committee on Energy and Commerce.
Jun 15, 2011
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Gestational Diabetes Act of 2011 or the GEDI Act - Amends the Public Health Service Act to direct the Director of the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes research project within the diabetes program of the CDC to expand and enhance surveillance data and public health research on gestational diabetes. 

Requires the Secretary of Health and Human Services (HHS) to expand and intensify public health research on gestational diabetes, including; (1) developing and testing novel approaches for improving postpartum testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; and (2) conducting research to further understanding of the factors and health systems that influence the risk of gestational diabetes and the development of type 2 diabetes in women with a history of gestational diabetes.

Requires the Director to: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and Indian tribal-based diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.

What's happening now June 22, 2011

Referred to the Subcommittee on Health.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2194: GEDI Act. 112th Congress. Open America. https://openamerica.io/bill/112-HR-2194/
MLA
"H.R. 2194: GEDI Act." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-2194/.
Bluebook (legal)
H.R. 2194, 112th Cong. (2026), https://openamerica.io/bill/112-HR-2194/.
Markdown link
[H.R. 2194: GEDI Act](https://openamerica.io/bill/112-HR-2194/)
Report a problem